What is Gyre Therapeutics, Inc.'s gyre — revenue?

Gyre Therapeutics, Inc. (GYRE) reported gyre — revenue of $8K in Q2 2026.

What does gyre — revenue mean?

This represents the total revenue generated by the business segment from its primary commercial activities, excluding any sales-related taxes. It reflects the core top-line performance and market demand for the segment's products or services. Monitoring this metric helps investors assess the segment's ability to monetize its offerings and achieve commercial scale.

Gyre Therapeutics, Inc. (GYRE) Gyre — Revenue

Screener

Other segment segments

Gyre Pharmaceuticals

$29.1M+8.7%

Similar metrics at other companies

LBTYBWyre — Revenue

$197.8M+1.4%

SPXCRevenues — Revenue

$394M+22.0%

ORCLCloud Revenues — Revenue

$9.91B+47.1%

ORCLSoftware Revenues — Revenue

$6.82B-2.1%

OWLPerformance revenues — Revenue

$6.07M-3.9%

CNKOther Revenues — Revenue

$113.1M+18.2%

Other financials

Income statement

See full

Revenue$29.1M-2.1%

Gross profit$26.9M-5.9%

Operating income-$14.4M-541%

Net income-$11.7M-471%

EPS (diluted)-$0.12-300%

Balance sheet

See full

Cash & equivalents$43.3M+18.6%

Total debt$3.4M+145%

Total equity$107.9M+17.3%

Total assets$199.3M+30.5%

Cash flow

See full

Operating cash flow-$16.7M-124%

CapEx$262.0K-21.8%

Free cash flow-$17.0M-118%

Valuation

See full

Market cap$712.55M+11.2%

Enterprise value$672.68M+11.0%

P/S6×-0.1×

Profitability

See full

Gross margin94.3%-1.7pp

Operating margin-14%-18.7pp

Net margin-13.4%-15.1pp

FCF margin-5.1%—

Returns & leverage

See full

Return on equity-16%-18.3pp

Debt / equity0×0.0×

Current ratio4.3×-1.1×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026.

Filed: Aug 7, 2026, 5:00 PM EDT
Fiscal quarter: Q2 FY2026
Calendar quarter: Q2 2026
Accession: 0001193125-26-340448

Line item	Three Months Ended June 30,	Six Months Ended June 30,
	2025(As Recast)	2025(As Recast)
Revenues	$$29,734	$$60,305
Operating expenses:
Cost of revenues	1,151	2,045
Selling and marketing	15,195	26,035
Research and development	8,351	16,442
Research and development - related parties	—	—
General and administrative	7,277	15,481

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Gyre Therapeutics, Inc.'s gyre — revenue?: Gyre Therapeutics, Inc. (GYRE) reported gyre — revenue of $8K in Q2 2026.
What does gyre — revenue mean?: This represents the total revenue generated by the business segment from its primary commercial activities, excluding any sales-related taxes. It reflects the core top-line performance and market demand for the segment's products or services. Monitoring this metric helps investors assess the segment's ability to monetize its offerings and achieve commercial scale.